![Eva-Lotta Allan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eva-Lotta Allan
Directeur/Membre du Conseil chez
ALMIRALL, S.A.
Fortune : 30 873 $ au 30/06/2026
Profil
Eva-Lotta Allan currently works at Maxion Therapeutics Ltd., as Non-Executive Chairman from 2023, Draupnir Bio ApS, as Non-Executive Chairman from 2021, Almirall SA, as Independent Non-Executive Director from 2020, Crescendo Biologics Ltd., as Non-Executive Director from 2018, and Zelluna ASA, as Director from 2025.
Ms. Allan also formerly worked at C4X Discovery Holdings Plc, as Non-Executive Chairman from 2018 to 2023, Novavax AB, as Non-Executive Director in 2010, Vertex Pharmaceuticals (Europe) Ltd., as Senior Director-Global Business Development from 2000 to 2006, The Bioindustry Association, as Director, Immunocore Holdings Plc, as Director & Chief Business Officer from 2013 to 2018, Circio Holding ASA, as Independent Director from 2015 to 2023, Aleta Biotherapeutics, Inc., as Non-Executive Director from 2019 to 2024, Karolinska Institutet, as Principal, Oxford Asymmetry International Plc, as Principal, Oxford GlycoSciences Plc, as Principal, GE Healthcare Ltd. (United Kingdom), as Principal, and Ablynx NV, as Chief Business Officer from 2010 to 2013.
Ms. Allan received her undergraduate degree from the University of Stockholm.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,06 % | 31/12/2025 | 16 250 ( 0,06 % ) | 30 873 $ | 30/06/2026 |
Postes actifs de Eva-Lotta Allan
| Sociétés | Poste | Début |
|---|---|---|
| ALMIRALL, S.A. | Directeur/Membre du Conseil | 01/07/2020 |
Maxion Therapeutics Ltd.
 Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures protein therapeutics for cardiovascular, autoimmune and chronic disorders | Président | 21/09/2023 |
Draupnir Bio ApS
 Draupnir Bio ApS BiotechnologyHealth Technology Operates as a biotechnology company that develops oral and small molecule degraders of extracellular diseases | Président | 01/06/2021 |
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the development of new medicines based on antibody fragment technology | Directeur/Membre du Conseil | 18/06/2018 |
Anciens postes connus de Eva-Lotta Allan
| Sociétés | Poste | Fin |
|---|---|---|
Aleta Biotherapeutics, Inc.
 Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops cell therapy solutions for cancers and transforms cellular therapeutics to allow a broader spectrum of cancer indications | Directeur/Membre du Conseil | 01/11/2024 |
| C4X DISCOVERY HOLDINGS PLC | Président | 20/06/2023 |
| CIRCIO HOLDING ASA | Directeur/Membre du Conseil | 01/05/2023 |
| IMMUNOCORE HOLDINGS PLC | Directeur/Membre du Conseil | 01/04/2018 |
| ABLYNX | Public Communications Contact | 04/05/2010 |
Formation de Eva-Lotta Allan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Almirall SA
 Almirall SA Pharmaceuticals: MajorHealth Technology Engages in the development, manufacture and sale of pharmaceuticals | Health Technology |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford Asymmetry International Plc
 Oxford Asymmetry International Plc Chemicals: SpecialtyProcess Industries Specializes in the discovery and development of new drugs | Process Industries |
Oxford GlycoSciences Plc
 Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Developes and manufactures novel products for the diagnosis and treatment of human disease | Health Technology |
Novavax AB
 Novavax AB Pharmaceuticals: GenericHealth Technology Develops, manufactures, and sells vaccine adjuvants | Health Technology |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology Provides transformational medical technologies and services | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
University of Stockholm
 University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vertex Pharmaceuticals (Europe) Ltd.
 Vertex Pharmaceuticals (Europe) Ltd. Medical DistributorsDistribution Services Supplies pharmaceutical products | Distribution Services |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services Operates as a association to encourage and promote bioscience sector | Commercial Services |
Crescendo Biologics Ltd.
Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the development of new medicines based on antibody fragment technology | Commercial Services |
Circio Holding ASA
 Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
C4X Discovery Holdings Plc
 C4X Discovery Holdings Plc Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Health Technology |
Aleta Biotherapeutics, Inc.
Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops cell therapy solutions for cancers and transforms cellular therapeutics to allow a broader spectrum of cancer indications | Commercial Services |
Draupnir Bio ApS
Draupnir Bio ApS BiotechnologyHealth Technology Operates as a biotechnology company that develops oral and small molecule degraders of extracellular diseases | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Maxion Therapeutics Ltd.
Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures protein therapeutics for cardiovascular, autoimmune and chronic disorders | Health Technology |
Choisissez Zonebourse 
